000			01647 a2200457 4500
005			20250517033028.0
264		0	_c20160412
008			201604s 0 0 eng d
022			_a1873-5177
024	7		_a10.1016/j.pbb.2015.05.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aKumar, Ashwani
245	0	0	_aEfficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia. _h[electronic resource]
260			_bPharmacology, biochemistry, and behavior _cAug 2015
300			_a20-30 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aBody Weight _xdrug effects
650	0	4	_aBrain Chemistry _xdrug effects
650	0	4	_aCilostazol
650	0	4	_aDementia, Vascular _xdrug therapy
650	0	4	_aDiabetes Mellitus, Experimental _xcomplications
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aInflammation _xmetabolism
650	0	4	_aMale
650	0	4	_aMaze Learning _xdrug effects
650	0	4	_aMemory _xdrug effects
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aPhosphodiesterase Inhibitors _xpharmacology
650	0	4	_aPsychomotor Performance _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aTetrazoles _xpharmacology
700	1		_aKumar, Amit
700	1		_aJaggi, Amteshwar S
700	1		_aSingh, Nirmal
773	0		_tPharmacology, biochemistry, and behavior _gvol. 135 _gp. 20-30
856	4	0	_uhttps://doi.org/10.1016/j.pbb.2015.05.006 _zAvailable from publisher's website
999			_c24913589 _d24913589